» KV Pharmaceutical's Motion for Rule 11 Sanctions in Ritalin LA Case Denied
Celgene and Novartis v. KV Pharm. , No. 07-4819 KV Pharmaceutical filed an ANDA for a generic version of Ritalin LA with paragraph IV certifications to Celgene’s U.S. Patent Nos.